Shanghai Haohai Biological Technology Co Ltd 2023 AR2
The report highlights Shanghai Haohai Biological Technology's financial and sustainability performance for 2023, showcasing a 25.27% increase in revenue to RMB 2,634.91 million. The company advanced its product innovation in ophthalmology and medical aesthetics, securing registration for its hydrophobic molded aspheric intraocular lens. On the environmental front, Haohai obtained ISO 14001 certification and established energy and carbon reduction targets for 2025. Additionally, the company prioritized employee development and safety, reporting zero work-related fatalities over the past three years.
Company: Shanghai Haohai Biological Technology Co Ltd
Sector: Manufacturing
Country: China
Year: 2023
Type: AR2
Pages: 251
Back to company
Shanghai Haohai Biological Technology Co Ltd
Annual Report
The report highlights Shanghai Haohai Biological Technology's financial and sustainability performance for 2023, showcasing a 25.27% increase in revenue to RMB 2,634.91 million. The company advanced its product innovation in ophthalmology and medical aesthetics, securing registration for its hydrophobic molded aspheric intraocular lens. On the environmental front, Haohai obtained ISO 14001 certification and established energy and carbon reduction targets for 2025. Additionally, the company prioritized employee development and safety, reporting zero work-related fatalities over the past three years.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Workplace Fatalities
Employees